Learn More
BACKGROUND Alterations in hedgehog signaling are implicated in the pathogenesis of basal-cell carcinoma. Although most basal-cell carcinomas are treated surgically, no effective therapy exists for locally advanced or metastatic basal-cell carcinoma. A phase 1 study of vismodegib (GDC-0449), a first-in-class, small-molecule inhibitor of the hedgehog pathway,(More)
Modern work is a highly social process, offering many cues for people to organize communication and access information. Shared physical workplaces provide natural support for tasks such as (a) <i>social reminding</i> about communication commitments and keeping track of collaborators and friends, and (b) <i>social data mining</i> of local(More)
BACKGROUND Everolimus, an oral inhibitor of the mammalian target of rapamycin (mTOR), has shown antitumour activity in patients with advanced pancreatic neuroendocrine tumours. We aimed to assess the combination of everolimus plus octreotide long-acting repeatable (LAR) in patients with low-grade or intermediate-grade neuroendocrine tumours (carcinoid). (More)
BACKGROUND We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer. METHODS We randomly assigned 1491 women with axillary node-positive breast cancer to six cycles of treatment with either TAC or FAC as adjuvant(More)
In a large online advertising system, adversaries may attempt to profit from the creation of low quality or harmful advertisements. In this paper, we present a large scale data mining effort that detects and blocks such adversarial advertisements for the benefit and safety of our users. Because both false positives and false negatives have high cost, our(More)
In a few short years, we have witnessed a massive uptake in the use of cell phones, personal digital assistants and hybrid devices that integrate phone, computer and Internet services. These devices communicate with one another and with traditional computers. Along with the Internet, they have transformed our computational environments into communication(More)
BACKGROUND Bevacizumab and erlotinib target different tumour growth pathways with little overlap in their toxic-effect profiles. On the basis of promising results from a phase 1/2 trial assessing safety and activity of erlotinib plus bevacizumab for recurrent or refractory non-small-cell lung cancer (NSCLC), we aimed to assess efficacy and safety of this(More)
PURPOSE PF-3512676 (formerly CpG 7909) is a novel Toll-like receptor 9-activating oligonucleotide with single-agent antitumor activity that augments preclinical rituximab efficacy. This Phase I trial was designed to investigate the safety, tolerability, and preliminary antitumor activity of PF-3512676 in combination with rituximab. EXPERIMENTAL DESIGN(More)
A fundamental unit for user interfaces to existing communications applications is the message. However, empirical studies showed that people typically see their communication in terms of other people they interact with and personal social networks. Furthermore, important tasks such as keeping in touch, or tracking communication status, are not well(More)